- Home
- CNO vs SLNO Comparison
CNO vs SLNO Comparison
Compare CNO & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNO
- SLNO
- Stock Information
- Founded
- CNO 1979
- SLNO 1999
- Country
- CNO United States
- SLNO United States
- Employees
- CNO N/A
- SLNO N/A
- Industry
- CNO Accident &Health Insurance
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CNO Finance
- SLNO Health Care
- Exchange
- CNO Nasdaq
- SLNO Nasdaq
- Market Cap
- CNO 3.8B
- SLNO 3.7B
- IPO Year
- CNO 1987
- SLNO 2014
- Fundamental
- Price
- CNO $41.25
- SLNO $47.70
- Analyst Decision
- CNO Hold
- SLNO Strong Buy
- Analyst Count
- CNO 5
- SLNO 9
- Target Price
- CNO $43.60
- SLNO $114.89
- AVG Volume (30 Days)
- CNO 554.9K
- SLNO 2.2M
- Earning Date
- CNO 11-03-2025
- SLNO 11-04-2025
- Dividend Yield
- CNO 1.65%
- SLNO N/A
- EPS Growth
- CNO 20.08
- SLNO N/A
- EPS
- CNO 2.98
- SLNO N/A
- Revenue
- CNO $4,441,500,000.00
- SLNO $98,675,000.00
- Revenue This Year
- CNO N/A
- SLNO N/A
- Revenue Next Year
- CNO $3.27
- SLNO $181.30
- P/E Ratio
- CNO $13.84
- SLNO N/A
- Revenue Growth
- CNO N/A
- SLNO N/A
- 52 Week Low
- CNO $34.63
- SLNO $41.50
- 52 Week High
- CNO $43.20
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- CNO 59.35
- SLNO 31.94
- Support Level
- CNO $39.19
- SLNO $66.12
- Resistance Level
- CNO $42.00
- SLNO $69.99
- Average True Range (ATR)
- CNO 0.87
- SLNO 3.71
- MACD
- CNO 0.08
- SLNO -2.47
- Stochastic Oscillator
- CNO 66.61
- SLNO 18.57
About CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.